Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) Invested Capital (2017 - 2025)

Historic Invested Capital for Selectis Health (GBCS) over the last 13 years, with Q3 2025 value amounting to $12.9 million.

  • Selectis Health's Invested Capital rose 6221.64% to $12.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.9 million, marking a year-over-year increase of 6221.64%. This contributed to the annual value of $13.7 million for FY2024, which is 3822.16% down from last year.
  • Per Selectis Health's latest filing, its Invested Capital stood at $12.9 million for Q3 2025, which was up 6221.64% from $12.3 million recorded in Q2 2025.
  • Selectis Health's 5-year Invested Capital high stood at $22.2 million for Q4 2023, and its period low was $1.4 million during Q3 2023.
  • In the last 5 years, Selectis Health's Invested Capital had a median value of $8.9 million in 2023 and averaged $9.7 million.
  • Its Invested Capital has fluctuated over the past 5 years, first tumbled by 7896.63% in 2021, then skyrocketed by 58353.63% in 2023.
  • Selectis Health's Invested Capital (Quarter) stood at $9.4 million in 2021, then plummeted by 65.48% to $3.2 million in 2022, then surged by 583.54% to $22.2 million in 2023, then plummeted by 38.22% to $13.7 million in 2024, then dropped by 6.28% to $12.9 million in 2025.
  • Its last three reported values are $12.9 million in Q3 2025, $12.3 million for Q2 2025, and $12.9 million during Q1 2025.